Zacks Initiates Coverage of Precipio With Outperform Recommendation

Zacks Investment Research has recently initiated coverage of Precipio, Inc. (PRPO) , assigning an "Outperform" recommendation to the company's shares. This bullish stance reflects the company's path to profitability and robust positioning within the cancer diagnostics space. Precipio, currently operating from New Haven, CT, focuses on cancer diagnostics. The company, which aims to address the incidence of cancer misdiagnoses through the development of diagnostic products and services, operates clinical labo ...